Pharma

amgen-beta-pharmaceuticals-will-bring-colon-cancer-drug-vectibix-to-the-chinese-market

Amgen forms JV to launch cancer drug in China

  • China
  • |
  • News

Singapore: US-based Amgen is going to enter into a joint venture with Chinese pharmaceutical firm Zhejiang Beta Pharma, in which Amgen will own 49 percent of interest. The new firm will be named Amgen-Beta Pharmaceuticals and will help... Read more

with-arms-wide-open-saudi-arabia-s-modern-healthcare-solutions-welcomes-malaysia-s-pharmaniaga-to-setup-a-pharmaceutical-manufacturing-plant-in-sudair-economic-city-in-riyadh

Malaysian pharma giant to setup plant in Saudi Arabia...


  • Malaysia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Malaysia-based Pharmaniaga has entered into a collaboration with Saudi Arabia-based Modern Healthcare Solutions... Read more

actavis-will-buy-warner-chilcott-for-usd8

Actavis buys women's health firm for $8.5 bn


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Actavis entered into a definitive agreement to acquire Dublin-based Warner Chilcott in a stock-for-stock... Read more

singapore-continues-to-enhance-its-biomedical-sciences-cluster

Singapore: Rides the medtech wave

  • Singapore
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 1 Comment

With an aim to become the number 1 hotspot for global bioscience industry in Asia, Singapore has committed $13.05 billion (S$16.1 billion)... Read more

ranbaxy-has-been-hit-hard-by-the-gavel

Ranbaxy pleads guilty, will pay $500 mn to the US

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: Ranbaxy Laboratories has reached a final settlement agreement regarding a previously disclosed investigation by the US Department... Read more

malaysia-is-emerging-as-a-bioscience-hub-for-international-life-science-companies-by-providing-them-smooth-passage-to-set-up-manufacturing-plants

Malaysia: Emerges as a manufacturing hub

  • Malaysia
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Malaysia is now emerging as a manufacturing hub for international pharmaceutical companies and provides them smooth passage to set up manufacturing... Read more

indian-life-science-is-leveraging-on-increasing-sales-of-generic-medicines-continued-growth-in-chronic-therapies-and-greater-penetration-in-rural-markets

India: Policy reforms enables bioscience sector

  • India
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Leveraging on the back of increasing sales of generic medicines, continued growth in chronic therapies and a greater penetration in rural... Read more

in-late-2012-the-national-development-and-reform-commission-ndrc-of-china-announced-a-new-price-cut-policy-for-pharmaceuticals-effective-from-february-1-2013

China: Shines despite slower pace of growth

  • China
  • |
  • Analysis
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The investments pouring in China are aligned with the government's plan to boost the pharmaceutical industry of the country in its 12th... Read more

the-australian-government-is-under-pressure-to-offer-drugs-at-affordable-prices-and-to-lower-cost-of-healthcare

Australia: Controls healthcare cost, drives market

  • Australia
  • |
  • Analysis
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressure on the government... Read more

nymalize-nimodipine-was-previously-granted-orphan-designation-which-provides-seven-years-of-market-exclusivity

Arbor gets FDA approval for its first NDA

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration (FDA) has approved Arbor Pharmaceutical's New Drug Application (NDA) for Nymalize (nimodipine)... Read more

farewell-ms-anna-protopapas-executive-vp-of-bd-takeda-will-replace-millennium-pharma-s-outgoing-ceo-ms-deborah-dunsire

CEO of Takeda's Millennium Pharma quits abruptly

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Ms Deborah Dunsire, CEO, Millennium Pharmaceuticals, is leaving the company in an abrupt departure. Ms Dunsire fueled the emergence... Read more

scinopharm-taiwan-and-coland-to-develop-generic-oncological-drugs-for-china

ScinoPharm, Coland develop cancer generics in China

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to develop a series of... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X